Receptor occupancy

Receptor occupancy is the fraction of a given receptor population that is bound by a substance at any moment, usually expressed as a percentage. A drug might occupy 30% of its target receptor at a low dose and 85% at a higher one — and the relationship between that fraction and the drug's effects is one of the foundational ideas in pharmacology.

Occupancy is distinct from the amount of a substance in the blood. What determines it is how much of the substance is available and how tightly it binds — its affinity for that receptor. A high-affinity drug can occupy a large share of a receptor pool at concentrations that would leave a lower-affinity drug barely registered.

How it works · its role

Occupancy reflects a competition for binding sites. A drug molecule and the receptor's natural ligand — dopamine, serotonin, an endogenous opioid peptide — associate with and dissociate from the same binding pocket continuously. The fraction held by the drug versus the endogenous molecule depends on the relative concentrations and affinities of both.

The relationship follows a characteristic S-shaped curve. The pivotal parameter is the concentration at which a substance occupies exactly half the available receptors. Below that point, occupancy climbs steeply with each dose increment; above it, the curve flattens as most binding sites are already taken.

Occupancy is also dynamic rather than fixed. It rises as concentrations build after dosing and falls as the substance is metabolised or redistributed — tracking, roughly, the onset and offset of effects.

Relevance to substances & effects

Receptor occupancy explains why a drug's effects do not scale in a straight line with dose. At low occupancy of opioid receptors, pain suppression predominates; as occupancy climbs, sedation and respiratory effects emerge at higher thresholds. Antipsychotics follow the same logic: modest D2 receptor occupancy is associated with therapeutic benefit, while substantially higher occupancy is linked to movement-related side effects.

The concept also clarifies the difference between full and partial agonists. A partial agonist may reach the same level of occupancy as a full agonist at a comparable dose, but each occupied receptor produces a weaker downstream signal — so the ceiling effect is built into the molecule, not just the dose.

For classic psychedelics, 5-HT₂A receptor occupancy is the proximate correlate of perceptual effects. For benzodiazepines, GABA-A receptor occupancy tracks closely with sedation and anxiety suppression. Knowing what fraction of a receptor population a substance occupies — and how that fraction shifts over time — is the starting point for most rigorous dose-response reasoning.